Skip to content

Stimulation of cathodic, anodic, alternating current and EMLA anesthetic ointment on pain level and comfort in painful hospital procedures

The comparison of using cathodal, anodal direct current stimulation and intermittent with combined analgesia ointment of lidocaine and prilocaine on pain and comfort levels in arterial, vein blood sampling and intramuscular injection processes

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240123060780N1
Enrollment
200
Registered
2024-01-27
Start date
2024-02-09
Completion date
Unknown
Last updated
2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain. Acute pain, not elsewhere classified

Interventions

patients in this group receive anodal direct current stimulation (1-5 mA) at the same time as the needle tip enters the skin. Electrical stimulation is performed by connecting the active electrode to
Patients in this group receive lidocaine (2.5%) and prilocaine (2.5%) local anesthetic ointment in the area of the needle tip one hour before the procedures. Intervention 3: Intervention group
patients in this group receive cathodal direct current stimulation (1-5 mA) at the same time as the needle tip enters the skin. Electrical stimulation is performed by connecting the active electrode t
patients in this group receive alternating current stimulation (1-5 mA) with a frequency of 50 Hz at the same time as the needle tip enters the skin. Electrical stimulation is performed by connecting

Sponsors

Kermanshah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Full consciousness, literacy, reading, writing, verbal ability and healthy vision, no addiction, the skin of the study area should be healthy, no peripheral edema in the intervention area, not taking sedatives and anesthetic during the last 24 hours, not having a pacemaker and implantable cardiac device and defibrillators, no history of diabetes and vascular diseases.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: Immediately and in minutes 1, 3 and 5. Method of measurement: The visual analog scale.

Secondary

MeasureTime frame
Comfort level. Timepoint: 5 minutes after each procedure. Method of measurement: The visual analog scale.;Heart rate. Timepoint: Before, immediately and in 1,3,5 minutes. Method of measurement: Using portable pulse oximetry.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRasoul Kavyannejad

Kermanshah University of Medical Sciences

r.kavyannejad@kums.ac.ir+98 83 3427 4618

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026